AACR Meeting Abstracts
HOME HELP FEEDBACK HOW TO CITE ABSTRACTS ARCHIVE CME INFORMATION SEARCH
Cancer ResearchClinical Cancer Research
Cancer Epidemiology Biomarkers & PreventionMolecular Cancer Therapeutics
Molecular Cancer ResearchCancer Prevention Research
Cancer Prevention Journals PortalCancer Reviews Online
Annual Meeting Education BookMeeting Abstracts Online
 QUICK SEARCH:   [advanced]




Services
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosny, G. A.
Right arrow Articles by Tayel, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hosny, G. A.
Right arrow Articles by Tayel, H.
[Fifth AACR International Conference on Frontiers in Cancer Prevention Research, Nov 12-15, 2006]


Biomarkers and Early Detection: Molecular Diagnostics

Biomonitoring environmental stresses in female endometrial carcinoma versus hyperplasia using HSP70 and HER-2/neu proteins.

Gihan A. Hosny, Jr. and Hanan Tayel

IGSR, University of Alexandria, Alexandria, Egypt

Abstract

B17

Background : The intracellular distribution of heat shock or stress-response proteins (HSP), that are triggered to be induced when a cell undergoes environmental stresses, has presumably protective function to enable cells to increase resistance to the harmful effects of pathogens, heavy metal, heat shock, chemical mutagens or carcinogens. HER-2/neu proto-oncogene is a member of epidermal growth factor receptor or erb gene family that plays a key role in the regulation of normal oncogenic cell growth and has been linked to prognosis and response to therapy. Objective: To examine the in vivo environmental stresses in female endometrial carcinoma versus hyperplasia using immunohistochemical staining of HSP70 and HER-2/neu proteins. Methods: In the present study, 25 cases of formalin-fixed, paraffin embedded human endometrial tissue sections were examined for the expression of HSP70 and HER-2/neu by immunohistochemistry using a rabbit antihuman HSP70 monoclonal antibody and a rabbit anti-human HER-2/neu polyclonal antibody, respectively. Results: Positive staining for HSP70, seen as fine dark brown granules mainly confined to the cytoplasm, was observed in all sections examined. There was marked cellular heterogeneity, ranging from cells completely devoid of staining or with faint staining in poorly differentiated endometrial carcinoma to cells with very intense nuclear and cytoplasmic staining (4+) in normal tissue adjacent to the dysplastic epithelium and in cases of simple endometrial hyperplasia, suggesting a possible protective role of HSP70 in the different stages of carcinogenesis. On the other hand, immunoreactivity for HER-2/neu showed different pattern. Positive strong staining was identified cytoplasmic and/or in cell membrane in poorly, moderately and well differentiated endometrial carcinomas. No immunostaining was observed in normal epithelium and in two cases of simple endometrial hyperplasia. Conclusion: The results suggest that HER-2/neu expression may play a role in the pathogenesis and progression of endometrial carcinoma and together with HSP70 could prove useful biomarkers for diagnosis or disease stratification.







HOME HELP FEEDBACK HOW TO CITE ABSTRACTS ARCHIVE CME INFORMATION SEARCH
Cancer ResearchClinical Cancer Research
Cancer Epidemiology Biomarkers & PreventionMolecular Cancer Therapeutics
Molecular Cancer ResearchCancer Prevention Research
Cancer Prevention Journals PortalCancer Reviews Online
Annual Meeting Education BookMeeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.